Abstract
This review outlines the oral treatment options available for treating skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus (MRSA) in the community and discusses the evidence supporting their use.
Original language | English |
---|---|
Pages (from-to) | 497-502 |
Number of pages | 6 |
Journal | International Journal of Antimicrobial Agents |
Volume | 33 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2009 |
Keywords
- Clindamycin
- Fusidic acid
- Linezolid
- Rifampicin
- Skin and soft-tissue infection
- Staphylococcus aureus
- Tetracycline
- Trimethoprim